Many of us are far too familiar with the term “arthritis.” Well, so are many of our dogs. The arthritis most of our dogs get is known as osteoarthritis, or OA. It is a challenging disease involving ...
PARSIPPANY, N.J.--(BUSINESS WIRE)--Zoetis Inc. (NYSE:ZTS) today announced that the U.S. Food and Drug Administration (FDA) has approved Librela™ (bedinvetmab injection) for the control of pain ...
Osteoarthritis (OA) is a painful, progressive and widespread joint disease that affects one in four adult dogs – and up to 80% of senior dogs. Synovetin OA®, an innovative radiotherapy injected ...
Company Remains Confident in the Safety and Effectiveness of Librela and Reaffirms Its Commitment to Supporting Veterinarians and Pet Owners in Helping Dogs with OA Live with Less Pain and Greater ...
17 client-owned dogs with radiographically confirmed OA received 1 mg intramuscular ElenaVet™ once a week for 10 weeks. Pain Severity Score (PSS) fell from 5.25 → 3.25 and Pain Interference Score (PIS ...
First long-acting canine anti-nerve growth factor monoclonal antibody therapy administered once every three months Approval marks major milestone in the company’s continued innovation for canine OA ...
Just like humans, older dogs often have osteoarthritis. They can take pain medication or even have surgery. But a veterinarian in Pennsylvania is having success with a new radioactive injection. One ...
Canine OA is a painful and progressive disease that is highly prevalent. In studies, 40% of dogs have signs of OA. 3,4 With an estimated 86 million dogs living in the U.S. households, a high ...
Osteoarthritis is a common, chronic and progressive joint disease characterized by the inflammation and breakdown of joints, leading to pain and mobility issues. Although the disease cannot be cured, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results